Press Releases.
Volition to Take Part in Nu.Q® Vet Commercial Strategy Webinar
Volition Announces Expansion of Availability of the Nu.Q® Vet Cancer Test Through IDEXX's Reference Laboratory Network
Volition Issues Business Review 2022
VolitionRx Limited Announces Third Quarter 2022 Financial Results and Business Update
Volition Announces Clinical Research Study with Oncovet
Volition to Participate in a Lung Cancer Screening Study in France
VolitionRx Limited Schedules Third Quarter 2022 Earnings Conference Call and Business Update
Volition Announces the Launch of the Nu.Q® Vet Cancer Screening Test in the U.S. and Europe Through Heska's Reference Laboratories
Volition Signs Global Supply Agreement for Nu.Q® Vet Cancer Test
Volition Appoints Mickie Henshall as an Independent Director
VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update
Volition Announces U.S. Clinical Study for NETs